000 | 01557 a2200409 4500 | ||
---|---|---|---|
005 | 20250514004924.0 | ||
264 | 0 | _c20010830 | |
008 | 200108s 0 0 eng d | ||
022 | _a0270-4137 | ||
024 | 7 |
_a10.1002/pros.1097 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRekasi, Z | |
245 | 0 | 0 |
_aRegulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide. _h[electronic resource] |
260 |
_bThe Prostate _cAug 2001 |
||
300 |
_a188-99 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aAndrogens _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCyclic AMP _xbiosynthesis |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 |
_aGrowth Hormone-Releasing Hormone _xantagonists & inhibitors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aProstate-Specific Antigen _xbiosynthesis |
650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xpharmacology |
700 | 1 | _aSchally, A V | |
700 | 1 | _aPlonowski, A | |
700 | 1 | _aCzompoly, T | |
700 | 1 | _aCsernus, B | |
700 | 1 | _aVarga, J L | |
773 | 0 |
_tThe Prostate _gvol. 48 _gno. 3 _gp. 188-99 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/pros.1097 _zAvailable from publisher's website |
999 |
_c11419729 _d11419729 |